Expression of mutant type-p53 products in H pylori-associated chronic gastritis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 10

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

315

HTML

1391

Figures (1-4)

466

Tables (1-3)

244

Sum=2416

Mar 14, 2007 (publication date) through Mar 7, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

H Pylori

World J Gastroenterol. Mar 14, 2007; 13(10): 1541-1546
Published online Mar 14, 2007. doi: 10.3748/wjg.v13.i10.1541

Table 2 Positive ratio of Immunohistochemical detection against p53 (PAb 240)

^bP < 0.01 vs before eradication in H pylori positive group.

Citation: Kodama M, Murakami K, Okimoto T, Sato R, Watanabe K, Fujioka T. Expression of mutant type-p53 products in H pylori-associated chronic gastritis. World J Gastroenterol 2007; 13(10): 1541-1546
URL: https://www.wjgnet.com/1007-9327/full/v13/i10/1541.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i10.1541